Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline
Open accessThe DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The objective is to formulate clinical practice guidelines for treating Cushing's syndrome. PARTICIPANTS: Participants include an Endocrine Society-appointed Task Force of experts, a methodologist, and a medical writer. The European Society for Endocrinology co-sponsored the guideline. EVIDENCE: The Task Force used the Grading of Recommendations, Assessment, Development, and Evaluation system to describe the strength of recommendations and the quality of evidence. The Task Force commissioned three systematic reviews and used the best available evidence from other published systematic reviews and individual studies. CONSENSUS PROCESS: The Task Force achieved consensus through one group meeting, several conference calls, and numerous e-mail communications. Committees and members of The Endocrine Society and the European Society of Endocrinology reviewed and commented on preliminary drafts of these guidelines. CONCLUSIONS: Treatment of Cushing's syndrome is essential to reduce mortality and associated comorbidities. Effective treatment includes the normalization of cortisol levels or action. It also includes the normalization of comorbidities via directly treating the cause of Cushing's syndrome and by adjunctive treatments (eg, antihypertensives). Surgical resection of the causal lesion(s) is generally the first-line approach. The choice of second-line treatments, including medication, bilateral adrenalectomy, and radiation therapy (for corticotrope tumors), must be individualized to each patient.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The guidelines provide a general definition of remission after resection of an ACTH-producing corticotroph tumor as morning serum cortisol levels <5 μg/dL (<138 nmol/L) or UFC <28-56 nmol/d (<10-20 μg/d) within 7 days of tumor resection (37).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Steroidogenesis inhibitors work by inhibiting one or more enzymes involved in steroidogenesis, decreasing cortisol and other steroid hormone production (37, 38).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Available medical therapies currently used in clinical practice to treat CS include medications from 3 classes: pituitary-directed therapies (for pituitary CD only), steroidogenesis inhibitors, and glucocorticoid receptor antagonists (37).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“In patients with CS, surgical resection of the causative lesion(s) is the first-line treatment option regardless of etiology.”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
In the citing paper
“Pituitary-directed therapies, including pasireotide (US/EU/Canada) and cabergoline (off-label use only), inhibit pituitary ACTH production and, in some cases, ectopic ACTH secretion from neuroendocrine tumors, thereby reducing downstream cortisol secretion (37, 128).”
From Measuring cortisol in Cushing syndrome: diagnosis, monitoring, and cortisol circadian rhythm improvement. (2026) · cites this paper as [37]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Grading quality of evidence and strength of recommendations
(2004) · BMJ · doi:10.1136/bmj.328.7454.1490 · Cited by 8,477
Kearon (2012) · doi:10.1378/chest.11-2301 · Cited by 6,119
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
Nieman, L. K., Biller, B. M. K., Findling, J. W., Newell-Price, J., Savage, M. O., Stewart, P. M., & Montori, V. M. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0125 · Cited by 2,718 · cited 2×
“(17) 2810 Nieman et al Guidelines on Cushing’s Syndrome Treatment J Clin Endocrinol Metab, August 2015, 100(8):2807–2831”
BackgroundSelf-citationKahn (2012) · doi:10.1378/chest.11-2296 · Cited by 2,693
Self-citationPrevention of VTE in Nonorthopedic Surgical Patients
Gould, M. K., Garcia, D. A., Wren, S. M., Karanicolas, P. J., Arcelus, J. I., Heit, J. A., & Samama, C. M. (2012) · Chest · doi:10.1378/chest.11-2297 · Cited by 2,131
Lacroix, A., Feelders, R. A., Stratakis, C. A., & Nieman, L. K. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61375-1 · Cited by 1,777
Self-citationMolitch, M. E., Clemmons, D. R., Malozowski, S., Merriam, G. R., & Vance, M. L. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0179 · Cited by 1,047
Cushing, H. (1964) · Journal of Neurosurgery · doi:10.3171/jns.1964.21.4.0318 · Cited by 851
Starkman, M. N., Gebarski, S. S., Berent, S., & Schteingart, D. E. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90079-f · Cited by 840
The natural history of cushing's syndrome
Plotz, C. M., Knowlton, A. I., & Ragan, C. (1952) · The American Journal of Medicine · doi:10.1016/0002-9343(52)90027-2 · Cited by 763
Cited by
Items 301–400 of 1,000
Hypercoagulability in Cushing’s syndrome: From arterial to venous disease
St‐Jean, M., Lim, D. S. T., & Langlois, F. (2021) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2021.101496 · Cited by 25
USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs
Treppiedi, D., Muro, G. D., Marra, G., Barbieri, A. M., Mangili, F., Catalano, R., Serban, A. L., Ferrante, E., Locatelli, M., Lania, A. G., et al. (2021) · Endocrine Related Cancer · doi:10.1530/erc-21-0093 · Cited by 25
Dopamine D2 receptor expression in the corticotroph cells of the human normal pituitary gland
Pivonello, R., Waaijers, M., Kros, J. M., Pivonello, C., de Angelis, C., Cozzolino, A., Colao, A. A. L., Lamberts, S. W. J., & Hofland, L. J. (2016) · Endocrine · doi:10.1007/s12020-016-1107-2 · Cited by 25
Medical Therapy for Cushing’s Syndrome in the Twenty-first Century
Tritos, N. A., & Biller, B. M. K. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2018.01.006 · Cited by 24
Self-citationUpdate and Practical Recommendations for the Use of Medical Treatment of Cushing Syndrome
Araujo-Castro, M., Lamas, C., Nowak, E., Newell-Price, J. D. C., Reincke, M., & Castinetti, F. (2026) · Endocrine Reviews · doi:10.1210/endrev/bnaf042 · Cited by 24
Self-citationUnmet needs in Cushing’s syndrome: the patients’ perspective
Valassi, E., Chiodini, I., Feelders, R. A., Andela, C. D., Abou-Hanna, M., Idres, S., & Tabarin, A. (2022) · Endocrine Connections · doi:10.1530/ec-22-0027 · Cited by 24
Self-citationDziałach, Ł., Sobolewska, J., Respondek, W., Wojciechowska-Luźniak, A., & Witek, P. (2022) · HORMONES · doi:10.1007/s42000-022-00397-4 · Cited by 24
Langlois, D. K., Fritz, M. C., Schall, W. D., Olivier, N. B., Smedley, R. C., Pearson, P. G., Bailie, M. B., & Hunt, S. W. (2018) · BMC Endocrine Disorders · doi:10.1186/s12902-018-0251-5 · Cited by 24
Puglisi, S., Perotti, P., Barbot, M., Cosio, P., Scaroni, C. M., Stigliano, A., Lardo, P., Morelli, V., Polledri, E., Chiodini, I., et al. (2018) · Endocrine Connections · doi:10.1530/ec-18-0400 · Cited by 24
Grasso, M., Boscaro, M., Scaroni, C. M., & Ceccato, F. (2018) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-018-0288-6 · Cited by 25
Simeoli, C., Ferrigno, R., Martino, M. C. D., Iacuaniello, D., Papa, F., Angellotti, D., Pivonello, C., Patalano, R., Negri, M., Colao, A. A. L., et al. (2019) · Journal of Endocrinological Investigation · doi:10.1007/s40618-019-01077-8 · Cited by 24
Surgical and radiosurgical treatment strategies for Cushing’s disease
Bunevičius, A., Laws, E. R., Vance, M. L., Iuliano, S., & Sheehan, J. P. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03325-6 · Cited by 24
Belaya, Z. E., Golounina, O. O., Mel'nichenko, G. A., Tarbaeva, N. V., Pashkova, E., Gorokhov, M., Kalashnikov, V., Dzeranova, L. K., Fadeev, V. V., Volchkov, P., et al. (2021) · Endocrine · doi:10.1007/s12020-021-02674-5 · Cited by 24
Bancos, I., Hatipoğlu, B., Yuen, K. C. J., Chandramohan, L., Chaudhari, S., & Moraitis, A. G. (2021) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2021.100256 · Cited by 24
Patient and Provider Perspectives on Postsurgical Recovery of Cushing Syndrome
Acree, R., Miller, C. M., Abel, B. S., Neary, N. M., Campbell, K. K., & Nieman, L. K. (2021) · Journal of the Endocrine Society · doi:10.1210/jendso/bvab109 · Cited by 24
Self-citationDai, C., Feng, M., Sun, B., Bao, X., Yao, Y., Deng, K., Ren, Z.-Y., Zhao, B., Lü, L., Wang, R., et al. (2021) · Endocrine · doi:10.1007/s12020-021-02848-1 · Cited by 24
Beltsevich, D. G., Mel'nichenko, G. A., Kuznetsov, N. S., Troshina, E. A., Platonova, N. M., Vanushko, V. E., Yukina, M. Y., & Молашенко, Н. В. (2016) · Endocrine Surgery · doi:10.14341/serg2016431-42 · Cited by 24
Recognition and Management of Ectopic ACTH Secreting Tumors
Elenius, H., & Nieman, L. K. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae194 · Cited by 23
Self-citationOutcomes of endoscopic transsphenoidal surgery for Cushing's disease
Brady, Z., Garrahy, A., Carthy, C., O’Reilly, M., Thompson, C. J., Sherlock, M., Agha, A., & Javadpour, M. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00679-9 · Cited by 23
Tritos, N. A., Fazeli, P. K., McCormack, A. I., Mallea-Gil, S., Pineyro, M. M., Christ‐Crain, M., Frara, S., Labadzhyan, A., Ioachimescu, A. G., Shimon, I., et al. (2021) · Pituitary · doi:10.1007/s11102-021-01170-3 · Cited by 23
Self-citationThe dopaminergic control of Cushing’s syndrome
Pivonello, R., Pivonello, C., Simeoli, C., Martino, M. C. D., & Colao, A. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-021-01661-x · Cited by 23
Pneumocystis pneumonia in patients with Cushing's syndrome: A French multicenter retrospective study
Lugat, A., Lasolle, H., François, M., Benhenda, N., Bricaire, L., Cornu, E., Cristante, J., Gitton, A., Hadoux, J., Kerlan, V., et al. (2022) · Annales d Endocrinologie · doi:10.1016/j.ando.2022.09.020 · Cited by 23
Utsumi, T., Iijima, S., Sugizaki, Y., Mori, T., Somoto, T., Kato, S., Oka, R., Endo, T., Kamiya, N., & Suzuki, H. (2023) · International Journal of Urology · doi:10.1111/iju.15218 · Cited by 23
Endocrine Outcomes After Pituitary Surgery
Buttan, A. K., & Mamelak, A. N. (2019) · Neurosurgery Clinics of North America · doi:10.1016/j.nec.2019.05.009 · Cited by 23
Nadezhdina, E. Y., Rebrova, O. Y., Grigoriev, A. Y., Иващенко, О. В., Неронович, А. В., Mel'nichenko, G. A., & Dedov, I. I. (2019) · Pituitary · doi:10.1007/s11102-019-00985-5 · Cited by 23
Zhang, Y., Zhou, T., Feng, S., Wang, W., Liu, H., Wang, P., Sha, Z., & Yu, X. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154432 · Cited by 23
PXR mediates mifepristone-induced hepatomegaly in mice
Yao, X., Jiao, T., Jiang, Y., Fan, S., Zhao, Y.-Y., Xiao, Y., Gao, Y., Li, F., Zhou, Y., Chen, P., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00633-4 · Cited by 23
Valassi, E., Aulinas, A., Glad, C. A. M., Johannsson, G., Ragnarsson, Ó., & Webb, S. M. (2017) · Clinical Endocrinology · doi:10.1111/cen.13414 · Cited by 23
Balomenaki, M., Vassiliadi, D. A., & Tsagarakis, S. (2022) · Pituitary · doi:10.1007/s11102-022-01226-y · Cited by 22
Evaluation of ketoconazole as a treatment for Cushing’s disease in a retrospective cohort
Viecceli, C., Mattos, A. C. V., Costa, M. C. B., de Melo, R. B., Rodrigues, T. D. C., & Czepielewski, M. A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1017331 · Cited by 22
Fredrick, F. C., Meda, A. K. R., Singh, B. P., & Jain, R. (2024) · Acute and Critical Care · doi:10.4266/acc.2024.00647 · Cited by 22
Cushing's disease in older patients: Presentation and outcome
Qiao, N., Swearingen, B., & Tritos, N. A. (2018) · Clinical Endocrinology · doi:10.1111/cen.13799 · Cited by 22
Club, P. P., Barbot, M., Ceccato, F., Lizzul, L., Daniele, A., Zilio, M., Gardiman, M. P., Denaro, L., Emanuelli, E., Vianello, F., et al. (2019) · Neurosurgical Review · doi:10.1007/s10143-019-01132-1 · Cited by 22
A study of thyroid functions in patients with Cushing’s syndrome: a single-center experience
Xiang, B., Tao, R., Liu, X., Zhu, X., He, M., Ma, Z., Yang, Y., Zhang, Z., Li, Y., Yao, Z., et al. (2019) · Endocrine Connections · doi:10.1530/ec-19-0309 · Cited by 22
The role of 68Ga-DOTA derivatives PET-CT in patients with ectopic ACTH syndrome
Ceccato, F., Cecchin, D., Gregianin, M., Ricci, G., Campi, C., Crimì, F., Bergamo, M., Versari, A., Lacognata, C. S., Rea, F., et al. (2020) · Endocrine Connections · doi:10.1530/ec-20-0089 · Cited by 22
Cassarino, M. F., Sesta, A., Pagliardini, L., Losa, M., Lasio, G. B., Cavagnini, F., & Giraldi, F. P. (2016) · Endocrine · doi:10.1007/s12020-016-0990-x · Cited by 22
Mifepristone in the treatment of the ectopic adrenocorticotropic hormone syndrome
Wannachalee, T., Turcu, A. F., & Auchus, R. J. (2018) · Clinical Endocrinology · doi:10.1111/cen.13818 · Cited by 22
Factors Affecting Dexamethasone Suppression Test Results
Berlińska, A., Świątkowska-Stodulska, R., & Sworczak, K. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1017-3217 · Cited by 22
Characterization of cyclic Cushing's disease using late night salivary cortisol testing
Jahandideh, D., Swearingen, B., Nachtigall, L. B., Klibanski, A., Biller, B. M. K., & Tritos, N. A. (2018) · Clinical Endocrinology · doi:10.1111/cen.13758 · Cited by 21
Self-citationNewell-Price, J., Fleseriu, M., Pivonello, R., Feelders, R. A., Gadelha, M. R., Lacroix, A., Witek, P., Heaney, A. P., Piacentini, A., Pedroncelli, A. M., et al. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae201 · Cited by 21
“The key treatment goals for Cushing syndrome are to normalize cortisol levels, alleviate signs and symptoms, and improve QoL [9, 10].”
Self-citationDiagnostic value of parameters from a spot urine sample for renal potassium loss in hypokalemia
Li, J., Ma, H., Lei, Y., & Wan, Q. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.10.024 · Cited by 21
Landry, J. P., Clemente-Gutiérrez, U., Pieterman, C. R. C., Chiang, Y., Waguespack, S. G., Jiménez, C., Habra, M. A., Halperin, D. M., Fisher, S. B., Graham, P. H., et al. (2022) · Surgery · doi:10.1016/j.surg.2022.03.014 · Cited by 21
Hypothalamic–pituitary–adrenal axis recovery after treatment of Cushing's syndrome
Balaško, A., Zibar, K., Kaštelan, D., & Dušek, T. (2022) · Journal of Neuroendocrinology · doi:10.1111/jne.13172 · Cited by 21
Rowe, N. E., Kumar, R., Schieda, N., Siddiqi, F. S., McGregor, T. B., McAlpine, K., Violette, P. D., Bathini, V., Eng, M. K., Izard, J., et al. (2023) · Canadian Urological Association Journal · doi:10.5489/cuaj.8248 · Cited by 21
Mohammedi, K., Bertherat, J. Y., Raverot, G., Drui, D., Reznik, Y., Castinetti, F., Chanson, P., Manon, F., Brossaud, J., & Tabarin, A. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad251 · Cited by 21
Self-citationEtomidate in Severe Cushing Syndrome: A Systematic Review
Muthukuda, D. T., Liyanarachchi, K., Jayawickreme, K. P., Mahesh, P. K. B., Ruwanga, V. G. D., Kumar, S., Subasinghe, C. J., & Newell-Price, J. D. C. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf039 · Cited by 21
Self-citationSexual Dimorphism in Cellular and Molecular Features in Human ACTH-Secreting Pituitary Adenomas
Giraldi, F. P., Cassarino, M. F., Sesta, A., Terreni, M., Lasio, G. B., & Losa, M. (2020) · Cancers · doi:10.3390/cancers12030669 · Cited by 21
Dai, C., Fan, Y., Liu, X.-H., Bao, X., Yao, Y., Wang, R., & Feng, M. (2020) · Neuroendocrinology · doi:10.1159/000509221 · Cited by 21
Recovery of hypothalamic‐pituitary‐adrenal axis in paediatric Cushing disease
Tatsi, C., Neely, M. L., Flippo, C. L., Bompou, M. E., Keil, M. F., & Stratakis, C. A. (2020) · Clinical Endocrinology · doi:10.1111/cen.14300 · Cited by 21
Osilodrostat: A Novel Steroidogenesis Inhibitor to Treat Cushing’s Disease
Dougherty, J. A., Desai, D. S., & Herrera, J. B. (2020) · Annals of Pharmacotherapy · doi:10.1177/1060028020968808 · Cited by 21
Outcome Squares Integrating Efficacy and Safety, as Applied to Functioning Pituitary Adenoma Surgery
de Vries, F., Lobatto, D. J., Verstegen, M. J. T., Schutte, P. J., Notting, I. C., Kruit, M. C., Ahmed, S. F., Pereira, A. M., van Furth, W. R., & Biermasz, N. R. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab138 · Cited by 21
Ferrière, A., & Tabarin, A. (2021) · La Presse Médicale · doi:10.1016/j.lpm.2021.104091 · Cited by 21
Self-citationCushing disease in pediatrics: an update
Concepción‐Zavaleta, M. J., Flórez, C. D. A., Aldave, J. E. Q., García-Villasante, E. J., Gariza-Solano, A. C., Durand‐Vásquez, M. D. C., Urteaga, L. A. C., & Zavaleta‐Gutiérrez, F. E. (2023) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2346074.037 · Cited by 20
Zhu, X., Farsh, T., Vis, D. J., Yu, I. P. L., Li, H., Liu, T., Sjöström, M., Shrestha, R., Kneppers, J., Severson, T., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci178604 · Cited by 20
Bunevičius, A., Kano, H., Lee, C., Kršek, M., Nabeel, A. M., El-Shehaby, A. M. N., Abdelkarim, K., Martínez-Moreno, N., Mathieu, D., Lee, J. Y. K., et al. (2020) · Journal of neurosurgery · doi:10.3171/2019.12.jns192836 · Cited by 20
Yuno, A., Kenmotsu, Y., Takahashi, Y., Nomoto, H., Kameda, H., Cho, K. Y., Nakamura, A., Yamashita, Y., Nakamura, J., Nakakubo, S., et al. (2020) · Endocrine Journal · doi:10.1507/endocrj.ej20-0613 · Cited by 20
Levoketoconazole: a novel treatment for endogenous Cushing's syndrome
Fleseriu, M., Auchus, R. J., Pivonello, R., Salvatori, R., Zacharieva, S., & Biller, B. M. K. (2021) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2021.1945440 · Cited by 20
Self-citationZandbergen, I. M., Huntoon, K. M., White, T. G., Bakker, L. E. H., Verstegen, M. J. T., Ghalib, L. M., van Furth, W. R., Pelsma, I. C. M., Dehdashti, A. R., Biermasz, N. R., et al. (2023) · Archives of Medical Research · doi:10.1016/j.arcmed.2023.102919 · Cited by 20
Severe Cushing’s syndrome due to small cell prostate carcinoma: a case and review of literature
Elston, M. S., Crawford, V., Swarbrick, M. J., Dray, M. S., Head, M., & Conaglen, J. V. (2017) · Endocrine Connections · doi:10.1530/ec-17-0081 · Cited by 20
Outcomes of Primary Transsphenoidal Surgery in Cushing Disease: Experience of a Tertiary Center
Keskin, F. E., Özkaya, H. M., Bolayırlı, M., Erden, S., Kadıoğlu, P., Tanrıöver, N., & Gazioğlu, N. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.07.014 · Cited by 20
Advances in adrenal tumors 2018
Crona, J., Beuschlein, F., Pacák, K., & Skogseid, B. M. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0138 · Cited by 21
Financial Conflicts of Interest Among Authors of Endocrine Society Clinical Practice Guidelines*
Irwig, M. S., Kyinn, M., & Shefa, M. C. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00526 · Cited by 20
Adrenocortical Cancer Treatment
Long, S. E., & Miller, B. S. (2019) · Surgical Clinics of North America · doi:10.1016/j.suc.2019.04.012 · Cited by 20
Measurement of salivary cortisone to assess the adequacy of hydrocortisone replacement
Raff, H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1228 · Cited by 19
Long-term blood pressure outcomes of laparoscopic adrenalectomy in trHTN patients
Deng, Y., Wang, H., Guo, X., Jiang, S., & Cai, J. (2021) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2021-0005 · Cited by 19
Birdwell, L., Lodish, M. B., Tirosh, A., Chittiboina, P., Keil, M., Lyssikatos, C., Belyavskaya, E., Feelders, R. A., & Stratakis, C. A. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2016.06.087 · Cited by 19
Łebek-Szatańska, A., Nowak, K. M., Zgliczyński, W., Baum, E., Żyłka, A., & Papierska, L. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018819825541 · Cited by 19
Guaraldi, F., Zoli, M., Asioli, S., Corona, G., Gori, D., Friso, F., Pasquini, E., Bacci, A., Sforza, A., & Mazzatenta, D. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01225-5 · Cited by 19
The Adrenal Cortex and Its Disorders
Hughes, C. R., Man, E., & Achermann, J. C. (2019) · Wiley eBooks · doi:10.1002/9781119152712.ch9 · Cited by 19
Evaluation of Cortisol Production in Aldosterone-Producing Adenoma
Inoue, K., Yamazaki, Y., Tsurutani, Y., Suematsu, S., Sugisawa, C., Saito, J., Omura, M., Sasano, H., & Nishikawa, T. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-119878 · Cited by 19
Barbot, M., Guarnotta, V., Zilio, M., Ceccato, F., Ciresi, A., Daniele, A., Pizzolanti, G., Campello, E., Frigo, A. C., Giordano, C. S. D. S., et al. (2018) · Endocrine · doi:10.1007/s12020-018-1669-2 · Cited by 19
De Novo Design of High-Performance Cortisol Luminescent Biosensors
Chen, J. Y.-H., Peng, X., Xi, C., Lee, G. R., Baker, D. A., & Yeh, A. H.-W. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c05004 · Cited by 18
Varlamov, E. V., Park, B., & Fleseriu, M. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf552 · Cited by 18
Nowak, E., Zhang, Q., Zhang, S., Yao, Z., Ye, H., Machado, M. C., Moises, C., Tóth, M., Stark, J., Yuen, K. C. J., et al. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00249-9 · Cited by 18
Self-citationLi, Y., Li, C., Qi, X., Yu, L. D., & Lin, L. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1177125 · Cited by 18
Pivonello, R., Fleseriu, M., Newell-Price, J. D. C., Shimatsu, A., Feelders, R. A., Kadıoğlu, P., Tabarin, A., Brue, T. C., Geer, E. B., Piacentini, A., et al. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02359-6 · Cited by 18
Self-citationLord, S. J., Horvath, A. R., Sandberg, S., Monaghan, P. J., Cobbaert, C. M., Reim, M., Tolios, A., Mueller, R., & Bossuyt, P. M. (2025) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2025.2453148 · Cited by 18
Qiao, J., Li, J., Zhang, W., Wang, C., Li, J., Jiang, S., Tan, H., Chen, Y., Liu, H., Cai, B., et al. (2021) · Endocrine Journal · doi:10.1507/endocrj.ej20-0837 · Cited by 18
Lase, I., Grönberg, M., Norlén, O., Stalberg, P. L. H., Welin, S., & Janson, E. T. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13030 · Cited by 18
Sharifi, G., Amin, A. A., Sabahi, M., Echeverry, N., Dilmaghani, N. A., Mousavinejad, S. A., Valizadeh, M., Davoudi, Z., Adada, B., & Borghei-Razavi, H. (2022) · BMC Endocrine Disorders · doi:10.1186/s12902-022-01069-5 · Cited by 18
Glucocorticoid Regulation of Food-Choice Behavior in Humans: Evidence from Cushing's Syndrome
Moeller, S. J., Couto, L., Cohen, V. V., Lalazar, Y., Makotkine, I., Williams, N., Yehuda, R., Goldstein, R. Z., & Geer, E. B. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00021 · Cited by 18
New and emerging drug therapies for Cushing’s disease
Störmann, S., & Schopohl, J. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1504021 · Cited by 18
Ollivier, M., Haissaguerre, M., Ferrière, A., & Tabarin, A. (2018) · European Journal of Endocrinology · doi:10.1530/eje-18-0694 · Cited by 18
Self-citationBroersen, L. H. A., van Haalen, F. M., Kienitz, T., Dekkers, O. M., Strasburger, C. J., Pereira, A. M., & Biermasz, N. R. (2019) · European Journal of Endocrinology · doi:10.1530/eje-19-0202 · Cited by 19
Manetti, L., Deutschbein, T., Schopohl, J., Yuen, K. C. J., Roughton, M., Kriemler‐Krahn, U., Tauchmanovà, L., Maamari, R., & Giordano, C. S. D. S. (2019) · Pituitary · doi:10.1007/s11102-019-00984-6 · Cited by 18
Österreichischer Blutdruckkonsens 2019
Hypertensiologie, Ö. G. F., Weber, T., Atherosklerosegesellschaft, Ö., Gesellschaft, Ö. D., Angiologie, Ö. G. F. I., Nephrologie, Ö. G. F., Gesellschaft, Ö. K., Neurologie, Ö. G. F., Schlaganfall-Gesellschaft, Ö., Allgemeinmedizin, Ö. G. F., et al. (2019) · Wiener klinische Wochenschrift · doi:10.1007/s00508-019-01565-0 · Cited by 18
Das, L., Bhansali, A. K., Pivonello, R., Dutta, P. R., Bhadada, S. K., Ahuja, C. K., Mavuduru, R. S., Kumar, S., Behera, A., Saikia, U. N., et al. (2020) · Pituitary · doi:10.1007/s11102-020-01047-x · Cited by 18
Lacroix, A. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad026 · Cited by 17
Adrenal Cushing’s syndrome in children
Guarnotta, V., Emanuele, F., Salzillo, R., & Giordano, C. S. D. S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1329082 · Cited by 17
LC-MSMS assays of urinary cortisol, a comparison between four in-house assays
Brossaud, J., Leban, M., Corcuff, J., de Casson, F. B., Loupp, A.-G. L., Masson, D., Moal, V., & Bach‐Ngohou, K. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2017-0806 · Cited by 17
Fleseriu, M., Iweha, C., Salgado, L. R., Mazzuco, T. L., Campigotto, F., Maamari, R., & Limumpornpetch, P. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00436 · Cited by 18
Choo, K. S., Yew, J., Tan, E. J. H., & Puar, T. H. K. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1168797 · Cited by 17
Clinical Spectrum of USP8 Pathogenic Variants in Cushing's Disease
Rebollar‐Vega, R., Zuarth-Vázquez, J. M., & Hernández-Ramírez, L. C. (2023) · Archives of Medical Research · doi:10.1016/j.arcmed.2023.102899 · Cited by 17
Geographic variation in cost of care for pituitary tumor surgery
Lee, C. C., Kimmell, K. T., Lalonde, A., Salzman, P., Miller, M. C., Calvi, L. M., Manuylova, E., Shafiq, I., & Vates, G. E. (2016) · Pituitary · doi:10.1007/s11102-016-0738-x · Cited by 17
Dynamic changes of central thyroid functions in the management of Cushing's syndrome
Doğanşen, S. Ç., Yalın, G. Y., Canbaz, B., Tanrıkulu, S., & Yarman, S. (2018) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000019 · Cited by 17
Miśkiewicz, P., Milczarek-Banach, J., Rutkowska-Hinc, B., Kondracka, A., & Bednarczuk, T. (2018) · Journal of Endocrinological Investigation · doi:10.1007/s40618-018-0907-z · Cited by 17
Crock, P., Lüdecke, D. K., Knappe, U. J., & Saeger, W. (2018) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2018-0262 · Cited by 17
Cabergoline may act as a radioprotective agent in Cushing's disease
Thakkar, K., Lila, A. R., Sarathi, V., Ramteke‐Jadhav, S., Goroshi, M., Memon, S. S., Krishnatry, R., Gupta, T., Jalali, R., Goel, A. H., et al. (2019) · Clinical Endocrinology · doi:10.1111/cen.14123 · Cited by 17
Uvelius, E., Höglund, P., Valdemarsson, S. V., & Siesjö, P. (2018) · Pituitary · doi:10.1007/s11102-018-0902-6 · Cited by 17
Pediatric pituitary neuroendocrine tumors–a 13-year experience in a tertiary center
Li, X., Deng, K., Zhang, Y., Feng, M., Xing, B., Lian, W., & Yao, Y. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1270958 · Cited by 16
Metadata
- Authors
- Nieman, L. K., Biller, B. M. K., Findling, J. W., Murad, M. H., Newell-Price, J., Savage, M. O., & Tabarin, A.
- Affiliations
- National Institutes of Health (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2015-08
- Volume
- 100
- Issue
- 8
- Pages
- 2807-2831
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC4525003
- OpenAlex
- W2127952551
- Semantic Scholar
- 4d26bfff9a2f2ea132ea661d03d84dc8b2293884
- Cited by
- 1,270
- References
- 213
- Citations by year
- 2026: 99 · 2025: 120 · 2024: 104 · 2023: 117 · 2022: 148 · 2021: 169 · 2020: 116 · 2019: 112 · 2018: 116 · 2017: 83 · 2016: 75 · 2015: 6
- FWCI
- 80.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- Cushing's syndrome, hypercortisolism, surgical resection, bilateral adrenalectomy, radiotherapy, corticotropinoma, comorbidity management, treatment selection
- MeSH terms
- Adrenal Gland Neoplasms, Adrenalectomy, Cushing Syndrome, Endocrinology, Humans, Patient Care Planning, Pituitary Neoplasms, Recurrence, Remission Induction, Evidence-Based Medicine, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.